FDA approves first non-invasive DNA test for colorectal cancer

Big news in the colorectal cancer prevention and screening community yesterday! In a never-before-seen move, the Food & Drug Administration (FDA) and Centers for Medicare & Medicaid Services (CMS) jointly proposed Cologuard as a new option for colorectal cancer screening.…  Read More

Colorectal Cancer Is (or Could Be) the Poster Child for Cancer Prevention

February is Cancer Prevention Month, and colorectal cancer (CRC) is a poster child, as one of the few cancers that can be literally seen and removed before it becomes cancer, or can be caught early enough in regular screening to…  Read More

FIT Beats All Other Screening for Effectiveness and Cost

In a computer simulation, FIT — fecal immunochemical testing — done every year saved more lives and cost the least of any colorectal cancer screening method, including colonoscopy. The computer model looked at 100,000 average risk people and compared screening…  Read More